The Tick App: Changing Behaviors With Educational Messaging

May 21, 2026 updated by: University of Wisconsin, Madison

The Use of Ecological Momentary Assessments to Assess Tick-borne Disease Risk

The goal of this work is to evaluate the use of ecological momentary assessments as a tool to assess risk and risk factors for tick encounters and tick-borne diseases. This study will be conducted across the United States, with a focus the upper Midwest and Northeast and with a focus on Wisconsin and will enroll up to 1000 people.

Study Overview

Status

Recruiting

Conditions

Detailed Description

In the United States, several online and smart-phone apps are available to ID a tick (TickID app, North Carolina State University), submit a picture of a tick (TickSpotters.org, an outreach tool within the larger TickEncounter resource center by the University of Rhode Island) or submit a tick for testing (among other public health agencies, TickReport.com by the University of Massachusetts Amherst). Although these tools are accessible throughout the U.S., they focus on the Northeast. In addition, they do not assess human behavior and tick encounters nor do these tools evaluate prevention and education strategies. A recent study in the Netherlands evaluated the use and effectiveness of a preventative and educational tick app ("Tekenbeet"). This app was well-appreciated, well-used, and improved the user's intention to implement preventative measures. This also illustrates the move of information acquisition from in-hand leaflets to information provision through smartphones.

In this study, data on human behavior regarding tick encounters and tick prevention measures will be obtained from a smartphone application using momentary assessments methodology to assess real time behavior and movement. Ecological momentary assessments are a methodological tool for gathering quantitative behavioral data in real-time, or within the framework of a participant's daily routine.

The daily logs feature provides researchers information about what the participant's activity, location, tick encounters, and prevention measures used. This study will analyze participants who complete 7 daily logs. Their daily logs will be analyzed against the types of educational messaging presented to them within the Tick App.

During a portion of the year the opening screen will contain a prevention message and daily log reminder instead of the home screen. The screen will provide a tick check reminder, a link to the daily log and for half the users the screen will also include a reminder about another prevention behavior (for example bathing/showering). Users will be randomly assigned to the two groups to assess if the additional prevention message increases prevention behavior (tick checks and showering/bathing) and the number of tick encounters.

Study Type

Interventional

Enrollment (Estimated)

3500

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Illinois
      • Urbana, Illinois, United States, 61801
        • Recruiting
        • University of Illinois
        • Sub-Investigator:
          • Becky Smith
    • Michigan
      • East Lansing, Michigan, United States, 48824
        • Recruiting
        • Michigan State University
        • Contact:
        • Sub-Investigator:
          • Jean Tsao
    • New York
      • New York, New York, United States, 10027
        • Recruiting
        • Columbia University
        • Principal Investigator:
          • Maria Diuk-Wasser
        • Sub-Investigator:
          • Heather Kopsco
    • Washington
      • Pullman, Washington, United States, 99164
        • Recruiting
        • Washington State University
        • Principal Investigator:
          • Pilar Fernandez

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Will to participate in 7 days worth of daily activity logs within the Tick App.
  • be able and willing to provide informed consent

Exclusion Criteria:

  • Completes less than 7 days worth of daily logs or completes 7+ daily logs but not within 12 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Tick App Educational Materials
Education about tick bite prevention
No Intervention: No Educational Messaging

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in number of tick prevention behaviors
Time Frame: up to 12 months
A goal of the intervention is to see an increase in tick prevention behaviors (tick checks and showering). To measure this, the change in number of tick prevention behaviors will be compared between groups. Data collected when participant completes 7 daily logs in app within 12 months.
up to 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in number of self-reported tick encounters
Time Frame: up to 12 months
A goal of the intervention is to see a decrease in self-reported tick encounters. To measure this, the change in number of self-reported tick encounters will be compared between groups. Data collected when participant completes 7 daily logs in app within 12 months.
up to 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Susan Paskewitz, University of Wisconsin, Madison
  • Principal Investigator: Lyric Bartholomay, University of Wisconsin, Madison

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 31, 2020

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

July 1, 2027

Study Registration Dates

First Submitted

March 11, 2025

First Submitted That Met QC Criteria

March 11, 2025

First Posted (Actual)

March 18, 2025

Study Record Updates

Last Update Posted (Actual)

May 26, 2026

Last Update Submitted That Met QC Criteria

May 21, 2026

Last Verified

October 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2018-0084
  • A073600 (Other Identifier: UW Madison)
  • 1U01CK000651-01-00 (Other Grant/Funding Number: Centers for Disease Control and Prevention)
  • 1U01CK000651-01 (U.S. NIH Grant/Contract)
  • Protocol Version 9/11/25 (Other Identifier: UW Madison)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Individual participant data collected during the trial, after the deidentification will be available to researchers for independent verification of study outcome or to conduct subsequent clinical research, whose proposed use of the data has been approved by an independent review committee identified for this purpose.

IPD Sharing Time Frame

Beginning 9 months after publication of primary outcomes and ending 2 years after that date.

IPD Sharing Access Criteria

Proposals should be directed to Susan Paskewitz, smpaskew@wisc.edu or Maria Diuk Wasser, mad2256@columbia.edu. If approved after review by regulatory counsel, requestors will enter into a formal data sharing agreement. Data will be shared via encrypted single-user file transmission protocol.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tick Bites

Clinical Trials on Educational Materials delivered via the Tick App

Subscribe